| Acute effects of lysergic acid diethylamide in healthy subjects Y Schmid, F Enzler, P Gasser, E Grouzmann, KH Preller, FX Vollenweider, ... Biological psychiatry 78 (8), 544-553, 2015 | 465 | 2015 |
| The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation KH Preller, M Herdener, T Pokorny, A Planzer, R Kraehenmann, ... Current Biology 27 (3), 451-457, 2017 | 394 | 2017 |
| MDMA enhances emotional empathy and prosocial behavior CM Hysek, Y Schmid, LD Simmler, G Domes, M Heinrichs, C Eisenegger, ... Social cognitive and affective neuroscience 9 (11), 1645-1652, 2014 | 377 | 2014 |
| Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders FX Vollenweider, KH Preller Nature Reviews Neuroscience 21 (11), 611-624, 2020 | 357 | 2020 |
| Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers R Kraehenmann, KH Preller, M Scheidegger, T Pokorny, OG Bosch, ... Biological psychiatry 78 (8), 572-581, 2015 | 332 | 2015 |
| Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor KH Preller, JB Burt, JL Ji, CH Schleifer, BD Adkinson, P Stämpfli, E Seifritz, ... Elife 7, e35082, 2018 | 310 | 2018 |
| Dynamic causal modelling revisited KJ Friston, KH Preller, C Mathys, H Cagnan, J Heinzle, A Razi, P Zeidman Neuroimage 199, 730-744, 2019 | 264 | 2019 |
| Effective connectivity changes in LSD-induced altered states of consciousness in humans KH Preller, A Razi, P Zeidman, P Stämpfli, KJ Friston, FX Vollenweider Proceedings of the National Academy of Sciences 116 (7), 2743-2748, 2019 | 257 | 2019 |
| Phenomenology, structure, and dynamic of psychedelic states KH Preller, FX Vollenweider Behavioral neurobiology of psychedelic drugs, 221-256, 2018 | 243 | 2018 |
| Effect of psilocybin on empathy and moral decision-making T Pokorny, KH Preller, M Kometer, I Dziobek, FX Vollenweider International Journal of Neuropsychopharmacology 20 (9), 747-757, 2017 | 194 | 2017 |
| Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study M Vonmoos, LM Hulka, KH Preller, F Minder, MR Baumgartner, ... Neuropsychopharmacology 39 (9), 2200-2210, 2014 | 183 | 2014 |
| Effects of serotonin 2A/1A receptor stimulation on social exclusion processing KH Preller, T Pokorny, A Hock, R Kraehenmann, P Stämpfli, E Seifritz, ... Proceedings of the National Academy of Sciences 113 (18), 5119-5124, 2016 | 178 | 2016 |
| Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset M Vonmoos, LM Hulka, KH Preller, D Jenni, MR Baumgartner, R Stohler, ... The British Journal of Psychiatry 203 (1), 35-43, 2013 | 177 | 2013 |
| Impaired emotional empathy and related social network deficits in cocaine users KH Preller, LM Hulka, M Vonmoos, D Jenni, MR Baumgartner, E Seifritz, ... Addiction biology 19 (3), 452-466, 2014 | 166 | 2014 |
| Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation R Kraehenmann, D Pokorny, L Vollenweider, KH Preller, T Pokorny, ... Psychopharmacology 234, 2031-2046, 2017 | 164 | 2017 |
| Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine D De Gregorio, A Aguilar-Valles, KH Preller, BD Heifets, M Hibicke, ... Journal of Neuroscience 41 (5), 891-900, 2021 | 162 | 2021 |
| Psilocybin induces time-dependent changes in global functional connectivity KH Preller, P Duerler, JB Burt, JL Ji, B Adkinson, P Stämpfli, E Seifritz, ... Biological psychiatry 88 (2), 197-207, 2020 | 142 | 2020 |
| The neural basis of psychedelic action AC Kwan, DE Olson, KH Preller, BL Roth Nature Neuroscience 25 (11), 1407-1419, 2022 | 128 | 2022 |
| Altered social and non-social decision-making in recreational and dependent cocaine users LM Hulka, C Eisenegger, KH Preller, M Vonmoos, D Jenni, K Bendrick, ... Psychological medicine 44 (5), 1015-1028, 2014 | 128 | 2014 |
| Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial R von Rotz, EM Schindowski, J Jungwirth, A Schuldt, NM Rieser, ... EClinicalMedicine 56, 2023 | 117 | 2023 |
